Publications
Here you will find a comprehensive collection of all publications of the Leibniz Institute of Virology up to the year 1974. Use the filter options on the left to search specifically by year, author, research unit and journal. The search field also allows you to explore specific topics.
1974 - 2025
Displaying results 1 to 10 of 11.
Search narrowed by:
Publication
| 2024
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1.
- Beschorner N, Künzle P, Voges M, Hauber I, Indenbirken D, Nakel J, Virdi S, Bradtke P, Lory NC, Rothe M, Paszkowski-Rogacz M, Buchholz F, Grundhoff A, Schambach A, Thirion C, Mittrücker HW, Schulze Zur Wiesch J, Hauber J, Chemnitz J
-
PLoS One,
Publication
| 2018
STK3 is a therapeutic target for a subset of acute myeloid leukemias.
- Camgoz A, Paszkowski-Rogacz M, Satpathy S, Wermke M, Hamann MV, von Bonin M, Choudhary C, Knapp S, Buchholz F
-
Oncotarget,
Publication
| 2016
Antiviral therapy of persistent viral infection using genome editing.
- Buchholz F, Hauber J
-
Curr Opin Virol,
Publication
| 2016
Cre Recombinase and Other Tyrosine Recombinases.
- Meinke G, Bohm A, Hauber J, Pisabarro MT, Buchholz F
-
Chem Rev,
Publication
| 2016
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity.
- Karpinski J, Hauber I, Chemnitz J, Schäfer C, Paszkowski-Rogacz M, Chakraborty D, Beschorner N, Hofmann-Sieber H, Lange UC, Grundhoff A, Hackmann K, Schrock E, Abi-Ghanem J, Pisabarro MT, Surendranath V, Schambach A, Lindner C, van Lunzen J, Hauber J, Buchholz F
-
Nat Biotechnol,
Publication
| 2015
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.
- Karimova M, Beschorner N, Dammermann W, Chemnitz J, Indenbirken D, Bockmann JH, Grundhoff A, Lüth S, Buchholz F, Schulze zur Wiesch J, Hauber J
-
Sci Rep,
Publication
| 2014
Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates.
- Karpinski J, Chemnitz J, Hauber I, Abi-Ghanem J, Paszkowski-Rogacz M, Surendranath V, Chakrabort D, Hackmann K, Schröck E, Pisabarro MT, Hauber J, Buchholz F
-
J Int AIDS Soc,
Publication
| 2013
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice.
- Hauber I, Hofmann-Sieber H, Chemnitz J, Dubrau D, Chusainow J, Stucka R, Hartjen P, Schambach A, Ziegler P, Hackmann K, Schröck E, Schumacher U, Lindner C, Grundhoff A, Baum C, Manz MG, Buchholz F, Hauber J
-
PLoS Pathog,
Publication
| 2013
Runx1 is essential at two stages of early murine B-cell development.
- Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Günther T, Alawi M, Bergholz U, Müller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C
-
Blood,
Publication
| 2012
Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.
- Mariyanna L, Priyadarshini P, Hofmann-Sieber H, Krepstakies M, Walz N, Grundhoff A, Buchholz F, Hildt E, Hauber J
-
PLoS One,
